Presidents
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar
Nicola Mozzillo
Director of the Department of Surgical Oncology B, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Scientific Board
Sanjiv Agarwala
Chief of Medical oncology and Hematology, St. Luke’s University Hospital and Temple University, Bethlehem, Pennsylvania
Paolo A. Ascierto
Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy, National Cancer Institute "Fondazione G. Pascale" of Naples, Italy
Gennaro Ciliberto
Scientific Director of the National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Reinhard Dummer
University of Zurich Hospital, Department of Dermatology, Zurich, Switzerland
Bernard A. Fox
Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon
Claus Garbe
University Professor of Dermatology, Head, Division of Dermatologic Oncology Department of Dermatology Eberhard Karls University Tuebingen (Stuttgart), Germany
Francesco M. Marincola
Chief Research Officer, Sidra Medical and Research Centre, Doha, Qatar
Giuseppe Masucci
Professor, Department of Oncology-Pathology, and KcRN, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden
Nicola Mozzillo
Director of the Department Melanoma and Soft Tissues, National Cancer Institute “Fondazione G. Pascale” of Naples, Italy
Michael Postow
Memorial Sloan Kettering Cancer Center, New York
Igor Puzanov
Director Early Phase Clinical Trials Program, Co-Leader Experimental Therapeutics Program, Chief Melanoma Section Department of Medicine Roswell Park Cancer Institute, Buffalo, NY
Magdalena Thurin
Program Director, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, NCI, NIH, Rockville, Maryland
Ena Wang
Division Chief of Translational Medicine, Sidra Medical and Research Centre, Doha, Qatar
Tara Withington
Executive Director, Society for Immunotherapy of Cancer, Milwaukee
For information please contact info@melanomabridge.org
